European Archives - Page 300 of 1177 - European Medical Journal

High Sugar Intake Linked to Premature Ageing in Childhood Cancer Survivors

A recent study has shed light on the concerning link between high sugar consumption and premature aging in adult survivors of childhood cancer.

Non-Invasive Ultrasound for SLD Assessment

This infographic explores how a non-invasive ultrasound-based technique could enhance the assessment of steatotic liver disease.

Tirzepatide Significantly Reduces Mortality and Kidney Risks in Type 2 Diabetes

A recent cohort study has highlighted the potential of tirzepatide to significantly improve clinical outcomes in patients with Type 2 diabetes.

Real-World Type 2 Diabetes Remission Through NHS Diet Programme

Discover how the NHS Type 2 Diabetes Path to Remission (T2DR) programme, has led to significant weight loss and diabetes remission in participants.

A Case of Mauriac Syndrome Caused by Social Inequities in Healthcare: A Call to Action

A 21-year-old female with a history of Type 1 diabetes mellitus (T1DM) with baseline HbA1c ranging from 8.8–12.5%, delayed menarche…

Meeting the growing demand for medical education quizzes

If you want to engage HCPs, you must deliver high-quality medical education. But are all companies taking advantage of interactive quizzes?

Study Uncovers Key Risk Factors for Monoclonal Gammopathy of Undetermined Significance

Research has identified several modifiable risk factors linked to monoclonal gammopathy of undetermined significance, by utilising advanced mass spectrometry techniques.

Text Messaging Programme Helps Teens Quit Vaping

A recent study revealed the effectiveness of a tailored, interactive text message program designed to help adolescents quit vaping.

High Infection Risk in Patients with Rheumatoid Arthritis Lung Disease

Patients with rheumatoid arthritis-associated interstitial lung disease face a significant risk of severe and often fatal infections, according to a new multicenter prospective study.

High-Risk Prostate Cancer Occasionally Mislabelled as Benign

A study shows that 8% of men with Gleason Grade Group 1 prostate cancer may have more aggressive disease. High PSA levels and extensive positive biopsy results are key risk factors.